Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy

NCT00004040 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped no patient accruals

Conditions

Leukemia
Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL: recombinant interferon alfa
BIOLOGICAL: rituximab

Sponsor

Hoag Memorial Hospital Presbyterian

Collaborators

[object Object]